Latest News - Milestones

Thursday, July 27, 2017 | Milestones, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Patent-Pending Dropless and LessDrops Formulations Exceed One Million Patient Eyes Milestone

Imprimis Pharmaceuticals announced that its core patent-pending ophthalmic formulations have now served more than 1 million patient eyes. Imprimis first began offering ophthalmic solutions to physicia…

Read the full story